PT-141
Bremelanotide, the melanocortin receptor agonist that enhances sexual desire through the central nervous system, not blood flow.
Category
Sexual Health
Frequency
As needed (30-60 min before)
Research
FDA Approved (Vyleesi)What is PT-141?
PT-141 (bremelanotide) is a synthetic melanocortin receptor agonist derived from Melanotan-2 that works on sexual desire at the brain level rather than the vascular level. It is FDA-approved as Vyleesi (2019) for hypoactive sexual desire disorder (HSDD) in premenopausal women. It is the only FDA-approved treatment for low sexual desire that works through the central nervous system. Browse the full peptide library for related compounds.
Unlike Viagra or Cialis which work by increasing blood flow to the genitals (PDE5 inhibition), PT-141 activates melanocortin-4 receptors (MC4R) in the brain, which modulate sexual arousal and desire. This means it works for desire, not just mechanical function. It affects both men and women, though the FDA approval is only for women.
The practical reality: PT-141 is popular in the biohacker and research peptide community for both men and women. For men, it is often used as an alternative or complement to PDE5 inhibitors, especially for psychological or desire-based sexual dysfunction rather than purely physical ED. For women, it addresses the desire component that PDE5 inhibitors do not touch at all.
It was derived from Melanotan-2 during research, when scientists noticed the sexual arousal side effect and isolated it. Unlike Melanotan-2, PT-141 does not cause significant tanning. For tanning effects, see Melanotan I or Melanotan-2.
In Vietnam, PT-141 is not available at Vietnamese pharmacies or hospitals. Vyleesi (the branded version) is not registered with the DAV. Available research-grade from regional suppliers. For verified suppliers, see the supply index. Verify purity via the COA guide. For legal context, see the peptide legality guide.
How It Works
MC4R Activation: Binds to melanocortin-4 receptors in the hypothalamus, activating neural pathways associated with sexual arousal and desire.
Central Mechanism: Works at the brain level, not the vascular level. Increases desire and arousal rather than just mechanical blood flow.
Gender-Independent: The melanocortin pathway is active in both male and female brains, which is why PT-141 works for both sexes unlike PDE5 inhibitors which primarily affect male physiology.
Benefits
- Enhanced sexual desire and arousal (both men and women)
- Works on desire, not just mechanical function
- FDA-approved for female HSDD (Vyleesi)
- Does not require daily dosing (used as needed)
- Alternative to PDE5 inhibitors for desire-based dysfunction
- No cardiovascular contraindications like PDE5 inhibitors
Dosing Protocol
| Phase | Dose | Frequency | Duration |
|---|---|---|---|
| Sexual enhancement | 1-2mg | Subcutaneous, 30-60 min before | As needed |
| Female HSDD (FDA) | 1.75mg | Subcutaneous, 45 min before | As needed |
| First-time trial | 0.5-1mg | Subcutaneous, 45 min before | Single dose |
Always start at the lowest effective dose and titrate up gradually.
Side Effects
Common
- ⚠Nausea (most common, 40% of users, usually mild)
- ⚠Facial flushing
- ⚠Headache
- ⚠Injection site reaction
Rare
- •Elevated blood pressure (transient)
- •Darkening of skin (less than Melanotan-2 but possible with repeated use)
Who Should NOT Use PT-141
- ✕Uncontrolled hypertension
- ✕Cardiovascular disease
- ✕Pregnancy or breastfeeding
- ✕Liver impairment
- ✕On medications that affect blood pressure
- ✕Do NOT use more than once in 24 hours
- ✕Do NOT use more than 8 times per month (FDA guidance)
What to Expect
Onset of effect. Increased sense of arousal and desire. Mild flushing common. Nausea possible (subsides within 30 to 60 minutes).
Peak effect window. Enhanced sexual responsiveness.
Effects gradually wear off. No hangover or rebound.
Works consistently but do not exceed 8 doses per month. Some users report diminishing returns with very frequent use.
FAQ
Q: Does PT-141 work for men?
A: Yes. Although the FDA approval (Vyleesi) is only for women, PT-141 works on melanocortin receptors in both male and female brains. Many men in the research peptide community use it for desire-based sexual dysfunction, especially when PDE5 inhibitors alone are not enough.
Q: How is PT-141 different from Viagra?
A: Completely different mechanism. Viagra increases blood flow to the genitals. PT-141 increases desire and arousal in the brain. They can be used together (different pathways, no interaction), and some men combine them for both desire and function.
Q: Will PT-141 cause tanning like Melanotan-2?
A: Minimal. PT-141 was derived from Melanotan-2 but engineered to target MC4R (sexual function) over MC1R (tanning). Some mild skin darkening is possible with heavy repeated use, but it is much less than Melanotan-2.
Where to Get PT-141 in Vietnam
See our community-verified supplier list with COA verification and cold-chain shipping to Vietnam.